Handheld FRET-Aptamer Sensor for Chem-Bio Threats

Award Information
Agency:
Environmental Protection Agency
Branch
n/a
Amount:
$79,984.36
Award Year:
2011
Program:
SBIR
Phase:
Phase I
Contract:
EP-D-11-033
Award Id:
n/a
Agency Tracking Number:
EP-D-11-033
Solicitation Year:
2010
Solicitation Topic Code:
J
Solicitation Number:
n/a
Small Business Information
4100 N.W. Loop 410, Ste. 230, San Antonio, TX, 78229-
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
154088710
Principal Investigator:
JohnBruno
(210) 731-0000
john.bruno@otcorp.com
Business Contact:
WilliamHenderson
(210) 731-0000
bhenders@otcorp.com
Research Institute:
n/a
Abstract
"Operational Technology Corporation (OpTech) proposes to couple the ultrasensitivity of fluorescence-based detection with the high selectivity of synthetic DNA aptamers as replacements for antibodies to detect chemical and biological (CB) terrorism threats in 10 minutes or less from a variety of swabbed surfaces and liquid matrices. OpTech has previously provided strong proof-of-concept for a rapid one-step (“bind and detect”) Fluorescence Resonance Energy Transfer (FRET) aptamer assay for foot and mouth disease virus (J. Biomolec. Techniques, 2008), a nerve gas core molecule (J. Fluorescence 2008) as well as collagen breakdown peptides and calcidiol to monitor bone metabolism in astronauts (J. Clin. Ligand Assay, 2007). This patent-pending FRET-aptamer assay technology can now be applied in lyophilized form in plastic cuvettes to detect a variety of CB analytes on-site with low ng/ml sensitivity using a commercial off-the-shelf (COTS) handheld and battery-operated fluorometer. In Phase 1, OpTech will screen its existing methylphosphonic acid (MPA; nerve agent core), soman derivative, and Botulinum toxin A (BoNT A) candidate DNA aptamer sequences for FRET assay potential. OpTech will also develop aptmers to “anthrose” surface glycoprotein terminal sugar for detection of Bacillus anthracis spores. In Phase 2, OpTech will fully develop and lyophilize the selected FRET-aptamer assays in plastic cuvettes for use with the sensitive COTS handheld fluorometer for facile, rapid, and cost-effective detection of MPA, sarin or soman, BoNTs and anthrax spores. OpTech will also expand its repertoire of assays in Phase 2 to include more CB treat agents (viral and bacterial agents of interest). The primary market for OpTech’s initial CB FRET-aptamer assays will be federal and state first responders as well as military personnel. Clearly, however, the one-step FRET-aptamer assay approach coupled to a handheld COTS fluorometer constitutes a platform technology with broad applications in clinical diagnostics, veterinary diagnostics, food safety testing, environmental and agricultural monitoring. "

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government